Your browser doesn't support javascript.
loading
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease.
Migliori, G B; Marx, F M; Ambrosino, N; Zampogna, E; Schaaf, H S; van der Zalm, M M; Allwood, B; Byrne, A L; Mortimer, K; Wallis, R S; Fox, G J; Leung, C C; Chakaya, J M; Seaworth, B; Rachow, A; Marais, B J; Furin, J; Akkerman, O W; Al Yaquobi, F; Amaral, A F S; Borisov, S; Caminero, J A; Carvalho, A C C; Chesov, D; Codecasa, L R; Teixeira, R C; Dalcolmo, M P; Datta, S; Dinh-Xuan, A-T; Duarte, R; Evans, C A; García-García, J-M; Günther, G; Hoddinott, G; Huddart, S; Ivanova, O; Laniado-Laborín, R; Manga, S; Manika, K; Mariandyshev, A; Mello, F C Q; Mpagama, S G; Muñoz-Torrico, M; Nahid, P; Ong, C W M; Palmero, D J; Piubello, A; Pontali, E; Silva, D R; Singla, R.
Afiliação
  • Migliori GB; Respiratory Diseases Clinical Epidemiology Unit, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.
  • Marx FM; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa, DSI-NRF South African Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South A
  • Ambrosino N; Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri IRCCS, Montescano (PV), Italy.
  • Zampogna E; Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy.
  • Schaaf HS; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • van der Zalm MM; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Allwood B; Division of Pulmonology, Department of Medicine, Stellenbosch University & Tygerberg Hospital, South Africa.
  • Byrne AL; Heart Lung Clinic St Vincent´s Hospital and Clinical School, University of New South Wales, Sydney, NSW, Australia, Partners In Health (Socios En Salud Sucursal), Lima, Peru.
  • Mortimer K; Liverpool School of Tropical Medicine, Liverpool, UK.
  • Wallis RS; Aurum Institute, Johannesburg, South Africa.
  • Fox GJ; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
  • Leung CC; Hong Kong Tuberculosis, Chest and Heart Diseases Association, Hong Kong.
  • Chakaya JM; Department of Medicine, Therapeutics, Dermatology and Psychiatry, Kenyatta University, Nairobi, Kenya, Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
  • Seaworth B; Heartland National TB Center of Excellence, San Antonio, TX, University of Texas Health Science Center, Tyler, TX, USA.
  • Rachow A; Division of Infectious Diseases and Tropical Medicine, Medical Centre of the University of Munich (LMU), Munich, Germany, German Center for Infection Research (DZIF), Partner Site Munich, Germany.
  • Marais BJ; The Children´s Hospital at Westmead and the University of Sydney WHO Collaborating Center in Tuberculosis, University of Sydney, Sydney, NSW, Australia.
  • Furin J; Harvard Medical School, Department of Global Health and Social Medicine, Boston, MA, USA.
  • Akkerman OW; University of Groningen, University Medical Center Groningen, department of Pulmonary diseases and Tuberculosis, Groningen, the Netherlands, University of Groningen, University Medical Center Groningen, TB center Beatrixoord, Groningen, the Netherlands.
  • Al Yaquobi F; TB and Acute Respiratory Diseases Section, Department of Communicable Diseases, Directorate General of Disease Surveillance and Control, Ministry of Health, Oman.
  • Amaral AFS; National Heart and Lung Institute, Imperial College London, London, UK.
  • Borisov S; Moscow Research and Clinical Center for Tuberculosis Control, Moscow Health Department, Moscow, Russian Federation.
  • Caminero JA; Mycobacterial Unit, Pneumology Department. University General Hospital of Gran Canaria "Dr. Negrin", Las Palmas, Gran Canaria, ALOSA TB Academy, Spain.
  • Carvalho ACC; Laboratório de Inovações em Terapias, Ensino e Bioprodutos (LITEB), Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil.
  • Chesov D; Department of Pneumology and Allergology, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova, Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.
  • Codecasa LR; TB Reference Centre, Villa Marelli Institute, Niguarda Hospital, Milan, Italy.
  • Teixeira RC; National Institute of Respiratory Diseases and the Environment (INERAM), Asunción, Paraguay, Radboud University Medical Center, TB Expert Center Dekkerswald, Department of Respiratory Diseases, Nijmegen - Groesbeek, The Netherlands.
  • Dalcolmo MP; Reference Center Hélio Fraga, Fundação Oswaldo Cruz (Fiocruz), Ministry of Health, Rio de Janeiro, RJ, Brazil.
  • Datta S; Department of clinical sciences, Liverpool School of Tropical Medicine, Liverpool, UK, Innovation For Health And Development (IFHAD) Laboratory for Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru, Innovacion Por la Salud Yel Desarollo, (IPSYD) Asociación Benéfica PRISMA, L
  • Dinh-Xuan AT; Université de Paris, APHP Centre, Lung Function Unit, Department of Respiratory Diseases, Cochin Hospital, Paris, France.
  • Duarte R; Institute of Public Health, Porto University; Medical School, Porto University; Hospital Centre of Vila Nova de Gaia/Espinho, Porto, Portugal.
  • Evans CA; Innovation For Health And Development (IFHAD) Laboratory for Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru, Innovacion Por la Salud Yel Desarollo, (IPSYD) Asociación Benéfica PRISMA, Lima, Peru, Department of Infectious Diseases, Imperial College London, London, UK.
  • García-García JM; Tuberculosis Research Programme SEPAR, Barcelona, Spain.
  • Günther G; Department of Pulmonology, Inselspital Bern, University of Bern, Switzerland.
  • Hoddinott G; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Huddart S; UCSF Center for Tuberculosis, University of California San Francisco, San Francisco, CA, UCSF Division of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, USA.
  • Ivanova O; Division of Infectious Diseases and Tropical Medicine, Medical Centre of the University of Munich (LMU), Munich, Germany, German Center for Infection Research (DZIF), Partner Site Munich, Germany.
  • Laniado-Laborín R; Clínica de Tuberculosis, Hospital General Tijuana, Universidad Autónoma De Baja California, Mexico.
  • Manga S; Medecins Sans Frontieres (MSF), Operational Center, Paris, France.
  • Manika K; Pulmonary Department, Aristotle University of Thessaloniki, "G. Papanikolaou" Hospital, Thessaloniki, Greece.
  • Mariandyshev A; Northern State Medical University, Northern Arctic Federal University, Arkhangelsk, Russian Federation.
  • Mello FCQ; Thoracic Diseases Institute, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
  • Mpagama SG; Kibong´oto Infectious Diseases Hospital, Kilimanjaro Christian Medical University College, Moshi Kilimanjaro, Tanzania.
  • Muñoz-Torrico M; Tuberculosis Clinic, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City.
  • Nahid P; UCSF Center for Tuberculosis, University of California San Francisco, San Francisco, CA, UCSF Division of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, USA.
  • Ong CWM; Infectious Disease Translational Research Programme, Department of Medicine, National University of Singapore, Yong Loo Lin School of Medicine, Singapore, National University of Singapore Institute for Health Innovation & Technology (iHealthtech), Singapore.
  • Palmero DJ; Pulmonology Division, Municipal Hospital F.J. Muñiz and Instituto Vaccarezza, Buenos Aires, Argentina.
  • Piubello A; Damien Foundation, Brussels, Belgium.
  • Pontali E; Department of Infectious Diseases, Galliera Hospital, Genoa, Italy.
  • Silva DR; Faculdade de Medicina, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.
  • Singla R; Department of TB and Respiratory Diseases, National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India.
Int J Tuberc Lung Dis ; 25(10): 797-813, 2021 10 01.
Article em En | MEDLINE | ID: mdl-34615577
ABSTRACT

BACKGROUND:

Increasing evidence suggests that post-TB lung disease (PTLD) causes significant morbidity and mortality. The aim of these clinical standards is to provide guidance on the assessment and management of PTLD and the implementation of pulmonary rehabilitation (PR).

METHODS:

A panel of global experts in the field of TB care and PR was identified; 62 participated in a Delphi process. A 5-point Likert scale was used to score the initial ideas for standards and after several rounds of revision the document was approved (with 100% agreement).

RESULTS:

Five clinical standards were defined Standard 1, to assess patients at the end of TB treatment for PTLD (with adaptation for children and specific settings/situations); Standard 2, to identify patients with PTLD for PR; Standard 3, tailoring the PR programme to patient needs and the local setting; Standard 4, to evaluate the effectiveness of PR; and Standard 5, to conduct education and counselling. Standard 6 addresses public health aspects of PTLD and outcomes due to PR.

CONCLUSION:

This is the first consensus-based set of Clinical Standards for PTLD. Our aim is to improve patient care and quality of life by guiding clinicians, programme managers and public health officers in planning and implementing adequate measures to assess and manage PTLD.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 3_ND / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Tuberculose / Pneumopatias Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Int J Tuberc Lung Dis Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 3_ND / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Tuberculose / Pneumopatias Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Int J Tuberc Lung Dis Ano de publicação: 2021 Tipo de documento: Article